A detailed history of Cortland Associates Inc transactions in Danaher Corp stock. As of the latest transaction made, Cortland Associates Inc holds 173,723 shares of DHR stock, worth $41 Million. This represents 6.35% of its overall portfolio holdings.

Number of Shares
173,723
Previous 150,861 15.15%
Holding current value
$41 Million
Previous $37.7 Million 28.13%
% of portfolio
6.35%
Previous 5.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$239.25 - $280.76 $5.47 Million - $6.42 Million
22,862 Added 15.15%
173,723 $48.3 Million
Q2 2024

Jul 29, 2024

BUY
$235.51 - $267.98 $126,704 - $144,173
538 Added 0.36%
150,861 $37.7 Million
Q1 2024

Apr 22, 2024

SELL
$224.58 - $256.19 $482,622 - $550,552
-2,149 Reduced 1.41%
150,323 $37.5 Million
Q4 2023

Jan 30, 2024

SELL
$185.1 - $233.13 $117,168 - $147,571
-633 Reduced 0.41%
152,472 $35.3 Million
Q3 2023

Oct 27, 2023

SELL
$233.08 - $265.59 $283,425 - $322,957
-1,216 Reduced 0.79%
153,105 $38 Million
Q2 2023

Aug 03, 2023

SELL
$224.99 - $256.14 $1.03 Million - $1.17 Million
-4,582 Reduced 2.88%
154,321 $37 Million
Q1 2023

Apr 20, 2023

SELL
$239.75 - $277.0 $805,799 - $930,997
-3,361 Reduced 2.07%
158,903 $40 Million
Q4 2022

Jan 27, 2023

SELL
$241.42 - $282.29 $453,386 - $530,140
-1,878 Reduced 1.14%
162,264 $0
Q3 2022

Nov 01, 2022

SELL
$247.06 - $1507.4 $282,389 - $1.72 Million
-1,143 Reduced 0.69%
164,142 $42.4 Million
Q2 2022

Jul 22, 2022

SELL
$237.11 - $299.66 $5.29 Million - $6.69 Million
-22,324 Reduced 11.9%
165,285 $41.9 Million
Q1 2022

May 03, 2022

SELL
$257.27 - $315.76 $2.54 Million - $3.11 Million
-9,860 Reduced 4.99%
187,609 $55 Million
Q4 2021

Feb 01, 2022

BUY
$292.08 - $329.01 $1.37 Million - $1.54 Million
4,687 Added 2.43%
197,469 $65 Million
Q3 2021

Nov 02, 2021

BUY
$272.21 - $332.43 $99,356 - $121,336
365 Added 0.19%
192,782 $58.7 Million
Q2 2021

Aug 02, 2021

BUY
$225.08 - $271.69 $207,523 - $250,498
922 Added 0.48%
192,417 $51.6 Million
Q1 2021

May 04, 2021

SELL
$212.38 - $245.9 $207,282 - $239,998
-976 Reduced 0.51%
191,495 $43.1 Million
Q4 2020

Feb 02, 2021

SELL
$212.5 - $245.46 $279,225 - $322,534
-1,314 Reduced 0.68%
192,471 $42.8 Million
Q3 2020

Oct 21, 2020

SELL
$177.16 - $215.33 $295,325 - $358,955
-1,667 Reduced 0.85%
193,785 $41.7 Million
Q2 2020

Jul 23, 2020

SELL
$128.7 - $176.83 $28.8 Million - $39.5 Million
-223,583 Reduced 53.36%
195,452 $34.6 Million
Q1 2020

Apr 30, 2020

SELL
$121.39 - $169.05 $1.48 Million - $2.06 Million
-12,187 Reduced 2.83%
419,035 $58 Million
Q4 2019

Jan 31, 2020

BUY
$133.47 - $153.48 $5.28 Million - $6.08 Million
39,593 Added 10.11%
431,222 $66.2 Million
Q3 2019

Nov 07, 2019

SELL
$135.4 - $146.47 $6.55 Million - $7.09 Million
-48,404 Reduced 11.0%
391,629 $56.6 Million
Q2 2019

Jul 25, 2019

SELL
$124.88 - $143.73 $746,657 - $859,361
-5,979 Reduced 1.34%
440,033 $62.9 Million
Q1 2019

Apr 26, 2019

SELL
$97.62 - $132.29 $862,277 - $1.17 Million
-8,833 Reduced 1.94%
446,012 $58.9 Million
Q4 2018

Feb 01, 2019

SELL
$94.85 - $109.54 $676,659 - $781,458
-7,134 Reduced 1.54%
454,845 $46.9 Million
Q3 2018

Oct 30, 2018

SELL
$98.13 - $108.9 $407,828 - $452,588
-4,156 Reduced 0.89%
461,979 $50.2 Million
Q2 2018

Jul 16, 2018

SELL
$96.1 - $103.24 $72,747 - $78,152
-757 Reduced 0.16%
466,135 $46 Million
Q1 2018

Apr 26, 2018

BUY
$92.16 - $103.8 $408,545 - $460,145
4,433 Added 0.96%
466,892 $45.7 Million
Q4 2017

Jan 24, 2018

BUY
$85.26 - $94.62 $1.11 Million - $1.23 Million
13,050 Added 2.9%
462,459 $42.9 Million
Q3 2017

Oct 25, 2017

BUY
$79.29 - $88.45 $35.6 Million - $39.8 Million
449,409
449,409 $38.6 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cortland Associates Inc Portfolio

Follow Cortland Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cortland Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cortland Associates Inc with notifications on news.